BTMD - Kapitalisasi marang volume dodolan Biote

Simbol lan logo merek Biote Corp (BTMD)

Regulatory oversight risks and the potential departure of partners are putting pressure on biote Corp. (BTMD). However, its leadership status in bioidentical pellet therapy grants the company significant pricing power. Expansion through physician training is facilitating market capture. The company's rolling P/S chart visualizes revenue valuation dynamics, where 0.20 reflects the current value of this parameter.

BTMD Kapitalisasi marang pendapatan biote.com (28.04.2023 - 13.11.2026)

Rincian metrik lan analitis perusahaan Biote Corp (BTMD)

- kuotasi saiki lan rata-rata prakiraan nilai:
- statistik kapitalisasi pasar:
Analisis fundamental perusahaan:biote.com, BTMD
Produk asli biote Corp

The P/S ratio compares market capitalization to annual sales volume, allowing for a rapid assessment of business value regardless of current profitability. The current P/S ratio of 0.20 reflects the market value of the biote Corp. (BTMD) distribution system for hormone therapies and medical devices, where the efficiency of logistics hubs directly impacts revenue and the asset's investment attractiveness.

Pesaing biote Corp.

HCA - Rega marang dodolan|Tenet Healthcare Corporation - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan FMS (Fresenius Medical Care AG)|Solventum Inc. - Multiplikator P/S|Rega marang dodolan Encompass|UHS (uhsinc.com) - Kapitalisasi marang pendapatan|davita.com - Rasio kapitalisasi pasar marang pendapatan|RDNT (RadNet) - Multiplikator P/S|Kapitalisasi marang pendapatan Option Care (OPCH)|Rasio rega marang pendapatan Surgery Partners Corp (SGRY)|PINC - Rega marang dodolan|Rasio rega marang pendapatan National Vision Holdings EYE|Rasio kapitalisasi pasar marang pendapatan PGNY|ARDT - Rasio rega marang pendapatan|Rasio rega marang dodolan SEM|ASTH (Apollo Medical Holdings) - Kapitalisasi marang pendapatan|MD - Koefisien rega marang pendapatan|USPH (US Physical Therapy) - Multiplikator P/S|Rasio rega marang pendapatan PNTG|Kapitalisasi marang pendapatan ORGO (Organogenesis)|Kapitalisasi marang volume dodolan NUTX|Rasio rega marang pendapatan Auna Health AUNA|SBC - Kapitalisasi marang pendapatan|Evolus, Inc. - Multiplikator P/S|CYH (chs.net) - Rasio kapitalisasi marang pendapatan|SKIN (beautyhealth.com) - Kapitalisasi marang pendapatan|MDWD: Kapitalisasi marang volume dodolan|Rasio rega marang pendapatan The Joint Corporation|DCGO: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S PIII|GANX - Rega marang dodolan|Multiplikator P/S EUDA (EUDA Health Holdings Limited)|Multiplikator P/S Basel Medical BMGL|CLGN: Kapitalisasi marang pendapatan|Cuprina Holdings Limited - Kapitalisasi marang volume dodolan|Concord Medical Services (CCM) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan ashs.com|MRM (MEDIROM Healthcare Group) - Multiplikator P/S|Rega marang dodolan Avalon GloboCare Corporation ALBT|Rasio rega marang pendapatan DIH Holding US Inc. (DHAI)|Carmell Corp - Rasio kapitalisasi marang pendapatan|NewGenIvf Group Limited - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan ATIP (ATI Physical Therapy Inc.)|CareMax - Multiplikator P/S|KDLY: Rasio rega marang pendapatan|MODV: Multiplikator P/S|NVOS - Koefisien rega marang pendapatan|Rasio rega marang pendapatan SunLink Health Systems Inc.|Rega marang dodolan imacholdings.comm BACK